Compare ABT & SCHW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ABT | SCHW |
|---|---|---|
| Founded | 1888 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 189.6B | 163.3B |
| IPO Year | N/A | 1987 |
| Metric | ABT | SCHW |
|---|---|---|
| Price | $110.65 | $105.02 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 18 | 16 |
| Target Price | ★ $141.00 | $114.25 |
| AVG Volume (30 Days) | ★ 13.4M | 9.8M |
| Earning Date | 01-22-2026 | 01-21-2026 |
| Dividend Yield | ★ 2.27% | 1.22% |
| EPS Growth | N/A | ★ 55.52 |
| EPS | 3.72 | ★ 4.65 |
| Revenue | ★ $44,328,000,000.00 | $23,921,000,000.00 |
| Revenue This Year | $8.92 | $12.60 |
| Revenue Next Year | $7.39 | $9.28 |
| P/E Ratio | $29.79 | ★ $22.60 |
| Revenue Growth | 5.67 | ★ 22.01 |
| 52 Week Low | $105.27 | $65.88 |
| 52 Week High | $141.23 | $105.81 |
| Indicator | ABT | SCHW |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 54.37 |
| Support Level | N/A | $101.57 |
| Resistance Level | N/A | $105.72 |
| Average True Range (ATR) | 0.00 | 2.36 |
| MACD | 0.00 | -0.23 |
| Stochastic Oscillator | 0.00 | 61.11 |
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
Charles Schwab is one of the largest retail-oriented financial-services companies in the US, with $11.6 trillion in client assets across its brokerage, banking, asset management, custody, financial advisory, and wealth-management businesses at the end of the third quarter. While best known for its retail brokerage offering, Schwab generates the lion's share of its revenue and profits through its Charles Schwab Bank and asset management segments. The firm is a dominant player in registered investment advisor custody, with over 40% market share, and has recently pushed into wealth management with robo-advisory, direct indexing, and other managed-investment solutions.